• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎谱系疾病患者的身体、情感、医学及社会经济状况:来自中国北方单一中心的123例横断面调查

Physical, Emotional, Medical, and Socioeconomic Status of Patients With NMOSD: A Cross-Sectional Survey of 123 Cases From a Single Center in North China.

作者信息

Jia Zhen, Dong XiuYu, Song Shuang, Guo Ruoyi, Zhang Lu, Liu Jia, Li Bin

机构信息

Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Neurological Laboratory of Hebei, Shijiazhuang, China.

出版信息

Front Neurol. 2021 Sep 8;12:737564. doi: 10.3389/fneur.2021.737564. eCollection 2021.

DOI:10.3389/fneur.2021.737564
PMID:34566879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8455822/
Abstract

This study aimed to assess the physical, emotional, medical, and socioeconomic conditions of patients with neuromyelitis optica spectrum disorder (NMOSD) in North China. A cross-sectional survey of patients with NMOSD was performed, based on an established questionnaire from the Multiple Sclerosis Patient Survival Report 2018. Logistic regression analysis was conducted to define the significant determinants of certain physical or emotional characteristics of patients. A total of 123 patients were included. A total of 63.4% of participants were initially diagnosed with conditions other than NMOSD, with a median delay of 6 months for accurate diagnosis. An aggregate of 72.2% of patients had one or more relapses, corresponding to an annual relapse rate of 0.8. Paresthesia was the most frequent physical symptom among patients both at disease onset (53.7%) and throughout the duration of the disease (86.2%). Onset in elderly (>50 years) patients was associated with an annual Expanded Disability Status Scale increase ≥1, compared with onset in younger (<30 years) patients ( = 0.001, OR = 7.83). A total of 76.4% of patients had received attack-prevention treatments in the remission phase, and 31.7 and 10.6% of patients had ever been administered rituximab and traditional Chinese medicine, respectively. Additionally, 63.4 and 43.1% of patients reported participating in few or no social activities and being out of work because of the disease. To be noted, 76.4% of patients reported suffering from negative emotions, with the most frequent being worry (60.2%), with 20.3% of patients experiencing suicidal thoughts. The inability to work and participating in few or no social activities due to NMOSD were two determinants of experiencing negative emotions ( = 0.03, OR = 3.34; = 0.02, OR = 3.19). This study reported patient perspectives on NMOSD in North China, whereby demonstrating that the inability to work and participating in few or no social activities due to NMOSD rather than the physical impairment caused by the disease, was directly associated with patients experiencing negative emotions. This insight offers potential ways to manage patients' negative emotions by enhancing family and social support and facilitating active employment.

摘要

本研究旨在评估中国北方视神经脊髓炎谱系障碍(NMOSD)患者的身体、情绪、医疗及社会经济状况。基于《2018年多发性硬化患者生存报告》中的既定问卷,对NMOSD患者进行了横断面调查。进行逻辑回归分析以确定患者某些身体或情绪特征的显著决定因素。共纳入123例患者。63.4%的参与者最初被诊断为非NMOSD疾病,准确诊断的中位延迟时间为6个月。72.2%的患者有一次或多次复发,年复发率为0.8。感觉异常是疾病发作时(53.7%)和整个病程中(86.2%)患者最常见的身体症状。老年(>50岁)患者发病时每年扩展残疾状态量表增加≥1,而年轻(<30岁)患者发病时则不然(P = 0.001,OR = 7.83)。76.4%的患者在缓解期接受了预防发作治疗,31.7%和10.6%的患者分别接受过利妥昔单抗和中药治疗。此外,63.4%和43.1%的患者报告很少或没有参加社交活动,并且因疾病而失业。值得注意的是,76.4%的患者报告有负面情绪,最常见的是担忧(60.2%),20.3%的患者有自杀念头。因NMOSD无法工作以及很少或没有参加社交活动是产生负面情绪的两个决定因素(P = 0.03,OR = 3.34;P = 0.02,OR = 3.19)。本研究报告了中国北方患者对NMOSD的看法,表明因NMOSD无法工作以及很少或没有参加社交活动,而非疾病导致的身体损伤,与患者产生负面情绪直接相关。这一见解为通过加强家庭和社会支持以及促进积极就业来管理患者的负面情绪提供了潜在途径。

相似文献

1
Physical, Emotional, Medical, and Socioeconomic Status of Patients With NMOSD: A Cross-Sectional Survey of 123 Cases From a Single Center in North China.视神经脊髓炎谱系疾病患者的身体、情感、医学及社会经济状况:来自中国北方单一中心的123例横断面调查
Front Neurol. 2021 Sep 8;12:737564. doi: 10.3389/fneur.2021.737564. eCollection 2021.
2
Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.中国视神经脊髓炎谱系障碍:生活质量与医疗护理体验。
Mult Scler Relat Disord. 2020 Nov;46:102542. doi: 10.1016/j.msard.2020.102542. Epub 2020 Sep 29.
3
The mediating effect of health-related hardiness on the degree of physical disability and perceived stress in Chinese female patients with neuromyelitis optica spectrum disorder.健康相关坚韧在影响中国女性视神经脊髓炎谱系疾病患者躯体残疾程度和感知压力中的中介作用。
Mult Scler Relat Disord. 2019 Oct;35:67-72. doi: 10.1016/j.msard.2019.07.017. Epub 2019 Jul 22.
4
Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city.伊朗伊斯法罕市患者接受利妥昔单抗治疗后 6 个月和 12 个月时,视神经脊髓炎(NMOSD)的疾病过程、进展和活动情况。
Mult Scler Relat Disord. 2019 Sep;34:77-82. doi: 10.1016/j.msard.2019.06.013. Epub 2019 Jun 20.
5
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.托珠单抗与硫唑嘌呤治疗高复发视神经脊髓炎谱系疾病的安全性和有效性(TANGO):一项开放标签、多中心、随机、2 期临床试验。
Lancet Neurol. 2020 May;19(5):391-401. doi: 10.1016/S1474-4422(20)30070-3.
6
Impact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders.利妥昔单抗对厄瓜多尔视神经脊髓炎谱系疾病患者复发率和残疾的影响。
Mult Scler Relat Disord. 2021 Feb;48:102683. doi: 10.1016/j.msard.2020.102683. Epub 2020 Dec 9.
7
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.韩国多中心回顾性研究:晚发性视神经脊髓炎谱系疾病的临床特征。
Mult Scler. 2017 Nov;23(13):1748-1756. doi: 10.1177/1352458516685416. Epub 2017 Jan 6.
8
Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy.口服泼尼松维持疗法对水通道蛋白4抗体相关视神经脊髓炎谱系障碍的优化管理
Mult Scler Relat Disord. 2021 Apr;49:102750. doi: 10.1016/j.msard.2021.102750. Epub 2021 Jan 22.
9
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.视神经脊髓炎谱系疾病伴发脊髓炎病史的患者长期残疾与发病年龄、诊断/预防治疗延迟、MRI 病变长度和症状性脑病变存在有关。
Mult Scler Relat Disord. 2019 Feb;28:64-68. doi: 10.1016/j.msard.2018.12.011. Epub 2018 Dec 9.
10
[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].视神经脊髓炎及视神经脊髓炎谱系障碍患儿的临床特征与随访
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73.

本文引用的文献

1
Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study.中国视神经脊髓炎谱系障碍(NMOSD)的发病率:一项基于全国人口的研究。
Lancet Reg Health West Pac. 2020 Sep 6;2:100021. doi: 10.1016/j.lanwpc.2020.100021. eCollection 2020 Sep.
2
Status of the neuromyelitis optica spectrum disorder in Latin America.拉丁美洲视神经脊髓炎谱系疾病的现状。
Mult Scler Relat Disord. 2021 Aug;53:103083. doi: 10.1016/j.msard.2021.103083. Epub 2021 Jun 15.
3
Mortality of neuromyelitis optica spectrum disorders in a Chinese population.
中国人群视神经脊髓炎谱系疾病的死亡率。
Ann Clin Transl Neurol. 2021 Jul;8(7):1471-1479. doi: 10.1002/acn3.51404. Epub 2021 Jun 13.
4
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.日本和德国的水通道蛋白4-IgG自身免疫:血清阳性视神经脊髓炎谱系障碍的临床特征和预后差异。
Mult Scler J Exp Transl Clin. 2021 May 4;7(2):20552173211006862. doi: 10.1177/20552173211006862. eCollection 2021 Apr-Jun.
5
Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of .中国多发性硬化症患者对免疫疗法的接受情况:……分析
Front Neurol. 2021 Apr 8;12:651511. doi: 10.3389/fneur.2021.651511. eCollection 2021.
6
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.全球视神经脊髓炎的发病率和患病率:一项系统评价。
Neurology. 2021 Jan 12;96(2):59-77. doi: 10.1212/WNL.0000000000011153. Epub 2020 Dec 11.
7
Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.中国视神经脊髓炎谱系障碍:生活质量与医疗护理体验。
Mult Scler Relat Disord. 2020 Nov;46:102542. doi: 10.1016/j.msard.2020.102542. Epub 2020 Sep 29.
8
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.抗髓鞘少突胶质细胞糖蛋白(MOG)抗体相关疾病:日本和德国的临床特征及预后差异
J Neurol Neurosurg Psychiatry. 2020 Nov 20. doi: 10.1136/jnnp-2020-324422.
9
Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study.应激性生活事件、社会经济地位与视神经脊髓炎谱系障碍的风险:一项基于人群的病例对照研究。
Mult Scler Relat Disord. 2020 Nov;46:102544. doi: 10.1016/j.msard.2020.102544. Epub 2020 Sep 29.
10
The clinical profile of NMOSD in Australia and New Zealand.澳大利亚和新西兰 NMOSD 的临床特征。
J Neurol. 2020 May;267(5):1431-1443. doi: 10.1007/s00415-020-09716-4. Epub 2020 Jan 31.